Previous close | 35.23 |
Open | N/A |
Bid | 36.50 |
Ask | 46.00 |
Strike | 270.00 |
Expiry date | 2026-01-16 |
Day's range | 35.23 - 35.23 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Upcoming community events will inform plans to create more equitable flying experiences for passengers with reduced mobility CAMBRIDGE, Mass. and ATLANTA, June 03, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Delta Flight Products (DFP), a wholly-owned subsidiary of Delta Air Lines established to create aircraft interior solutions to airlines around the world, announced that the companies will collaborate to inform future enhancements to the air travel journey for passengers with redu
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Biogen's (BIIB) Qalsody is the first therapy approved to treat a rare genetic form of ALS in Europe